ProCE Banner Activity

How I Manage Patients With HCV After DAA Treatment Failure

Clinical Thought
In the few HCV patients for whom DAA treatment fails, I consider a combination of 2 or more of the following: switching to a different DAA class, treating for longer, or adding ribavirin.

Released: January 19, 2016

Expiration: January 17, 2017

No longer available for credit.

Share

Faculty

Jordan J. Feld

Jordan J. Feld, MD, MPH

Assistant Professor of Medicine
University of Toronto
Hepatologist
Toronto Centre for Liver Diseases
Sandra Rotman Centre for Global Health
Toronto, Ontario, Canada

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Janssen

Faculty Disclosure

Primary Author

Jordan J. Feld, MD, MPH

Assistant Professor of Medicine
University of Toronto
Hepatologist
Toronto Centre for Liver Diseases
Sandra Rotman Centre for Global Health
Toronto, Ontario, Canada

Jordan J. Feld, MD, MPH, has disclosed that he has received funds for research support from Abbott, AbbVie, Gilead Sciences, Janssen, and Merck and consulting fees from AbbVie, Gilead Sciences, Janssen, and Merck.